Introduction of a Primary Point of Contact (PPoC) from July 1st 2021 onwards

In our 125 years history, Roche has continuously adapted to the changing needs of our stakeholders and the environment we are a part of, to best serve our patients. The burden of poor health is increasing and COVID-19 has reinforced the impending need to rethink how we work and collaborate within the healthcare ecosystem.

As we chart a new milestone with our 125-year history this year, we aim to transform towards being a strategic partner that provides integrated solutions in a sustainable manner. To fulfil this vision, we have made a significant shift by introducing a primary point of contact (PPoC) from July 1st 2021 onwards, to work closely with our stakeholders in the healthcare ecosystem supported by an integrated digital approach. With this, we want to ensure that our stakeholders have a one go-to-person at Roche for any of their needs, who will be able to collaborate with them when co-creating and co-implementing solutions for their patients.


Below are a list of contacts if you have any questions:

1. Orders:

  • Backlogged orders/replenishment of stocks
    Please contact Order Management team at Roche:

  • b. Contacting Zuellig Pharma
    Toll Free| Fax 1-800-88-1388

    Alternatively, their emails as below:

2. MY RPAP scheme
Go toor contact the hotline ator via email at

3. Information related to Roche products/Therapeutic and Disease Areas:
Go toor write in to

4. For other queries:
Please write in to

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

ContactLocationslinkedinfacebooktwitterinstagramyoutubeAbout RochePharma solutionsPersonalised healthcareCareersMediaPrivacy policyLegal statement